Search research articles
Contact Us
Filters
Showing results (151-160 of 189) with videos related to
Page
of 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2017
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL
Babafemi O Taiwo, Lu Zheng, Andrei Stefanescu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2022
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
Nigel Garrett, Asa Tapley, Jessica Andriesen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 10, 2013
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV
Deborah K McMahon, Lu Zheng, Jane Hitti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2015
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230
Nagalingeswaran Kumarasamy, Evgenia Aga, Heather J Ribaudo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 20, 2012
Automated sequence analysis and editing software for HIV drug resistance testing
Daniel Struck, Carole L Wallis, Gennady Denisov, et al.
BMC Infectious Diseases
|
June 15, 2016
Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm
Sarah E Rutstein, Mina C Hosseinipour, Morris Weinberger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 23, 2011
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa
Kim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa
Kim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 7, 2023
Qualification of the differential leukocyte count and immunophenotyping in cryopreserved ex vivo whole blood assay
Claire Imbratta, Anele Gela, Nicole Bilek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network
Raph L Hamers, Elske Straatsma, Cissy Kityo, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 189) with videos related to
Sort By:
Page
of 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 19, 2017
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL
Babafemi O Taiwo, Lu Zheng, Andrei Stefanescu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 19, 2022
High Rate of Asymptomatic Carriage Associated with Variant Strain Omicron
Nigel Garrett, Asa Tapley, Jessica Andriesen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 10, 2013
Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV
Deborah K McMahon, Lu Zheng, Jane Hitti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 20, 2015
Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230
Nagalingeswaran Kumarasamy, Evgenia Aga, Heather J Ribaudo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
March 20, 2012
Automated sequence analysis and editing software for HIV drug resistance testing
Daniel Struck, Carole L Wallis, Gennady Denisov, et al.
BMC Infectious Diseases
|
June 15, 2016
Predicting resistance as indicator for need to switch from first-line antiretroviral therapy among patients with elevated viral loads: development of a risk score algorithm
Sarah E Rutstein, Mina C Hosseinipour, Morris Weinberger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 23, 2011
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa
Kim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.
The Journal of Infectious Diseases
|
March 27, 2012
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa
Kim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 7, 2023
Qualification of the differential leukocyte count and immunophenotyping in cryopreserved ex vivo whole blood assay
Claire Imbratta, Anele Gela, Nicole Bilek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2012
Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network
Raph L Hamers, Elske Straatsma, Cissy Kityo, et al.
Page
of 19